This month marks a year since the malaria vaccine rollout began. Here's what we still need in order to beat a disease as old ...

SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...

With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

The fluent French speaker was teaching English in China when she wrote home asking for some anti-malaria pills. But after two doses she told her family in Swansea that the Lariam had made her ill ...

AI is being used across industries, and its role in drug discovery is pivotal as pharmaceutical companies seek to accelerate ...

FILE - COVID-19 antigen home tests indicating a positive result are photographed in New York, April 5, 2023. A study was ...

Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...

That has presented a "clear and present danger" that strains of P falciparum and other malaria parasites may emerge that are resistant to all current drugs. "These results are definitely good news ...

From fixing open gutters to educating kids about the importance of bed nets, a “whole-of-society” approach is needed to ...

"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop ...

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...